- E-postjan.jahnsen@uib.no
- BesøksadresseHaukeland universitetssykehus, Laboratoriebygget5009 Bergen
- PostadressePostboks 78045020 Bergen
Basal molekylærfarmakologi med ombygging av G protein-koblede reseptorer (GPCR).
Vitenskapelig artikkel
- (2021). Quetiapine, Misuse and dependency: A case-series of questions to a Norwegian network of drug information centers. Drug, Healthcare and Patient Safety. 151-157.
- (2018). Analysis of questions about use of drugs in breastfeeding to Norwegian drug information centres . International Breastfeeding Journal. 1-9.
- (2016). A new, simple and robust radioligand binding method used to determine kinetic off-rate constants for unlabeled ligands. Application at α2A- and α2C-adrenoceptors. European Journal of Pharmacology. 113-121.
- (2013). The C-terminal half of the alpha(2C)-adrenoceptor determines the receptor's membrane expression level and drug selectivity. Naunyn-Schmiedeberg's Archives of Pharmacology. 1031-1040.
- (2012). The predicted N-terminal signal sequence of the human alpha(2C)-adrenoceptor does not act as a functional cleavable signal peptide. European Journal of Pharmacology. 51-58.
- (2012). The N-terminal region of the human 5-HT2C receptor has as a cleavable signal peptide. European Journal of Pharmacology. 44-50.
Populærvitenskapelig artikkel
- (2015). Inspirerende foredrag om antibiotikaresistens. Norsk Farmaceutisk Tidsskrift.
Brev til redaktøren
- (2014). Perspective on the role of the N-terminal tail of the α2C-adrenoceptor. Naunyn-Schmiedeberg's Archives of Pharmacology. 10-1013.
Doktorgradsavhandling
- (2015). Predicted signal peptides, and the role of the N-terminal tail, at the monoamine G-protein coupled receptors 5-HT 2c and a2c.
Vitenskapelig oversiktsartikkel/review
- (2020). Ultrakort om farmakogenetikk. Utposten. 42-43.
- (2020). Review of questions concerning clinical drug interactions in ADHD treatment from physicians in Norway. Frontiers in Pharmacology.
Nettsider (opplysningsmateriale)
- (2024). RELIS og kunstig intelligens.
- (2016). Venlafaksin og risiko for kardiovaskulære bivirkninger.
Fagartikkel
- (2022). Bytte legemidler – hva bør man tenke på? Utposten. 54-55.
Se fullstendig oversikt over publikasjoner i CRIStin.
- Uhlen S, Jahnsen JA. Perspective on the role of the N-terminal tail of the α2C-adrenoceptor. Naunyn Schmiedebergs Arch Pharmacol. 2014 Oct;387(10):1013-4.
- Jahnsen JA, Uhlén S. The C-terminal half of the α2C-adrenoceptor determines the receptor's membrane expression level and drug selectivity. Naunyn Schmiedebergs Arch Pharmacol. 2013 Dec;386(12):1031-40.
- Jahnsen JA, Uhlén S. The predicted N-terminal signal sequence of the human α₂C-adrenoceptor does not act as a functional cleavable signal peptide. Eur J Pharmacol. 2012; 684(1-3): 51-8.
- Jahnsen JA, Uhlén S. The N-terminal region of the human 5-HT₂C receptor has as a cleavable signal peptide. Eur J Pharmacol 2012; 684(1-3): 44-50
- Rimmerman N, Bradshaw HB et al. N-palmitoyl glycine, a novel endogenous lipid that acts as a modulator of calcium influx and nitric oxide production in sensory neurons. Mol Pharmacol 2008; 74(1): 213-24.
- Walker JM, Krey JF et al. Targeted lipidomics: fatty acid amides and pain modulation. Prostaglandins Other Lipid Mediat 2005; 77(1-4): 35-45.
Utdannet cand. pharm. ved School of Pharmaceutical Sciences ved København Universitet. Jobber som rådgiver ved RELIS Vest